A Novel Bacteriocin from Enterococcus Faecalis 478 Exhibits a Potent Activity Against Vancomycin-resistant Enterococci

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Oct 13

PMID 29023515

Citations 24

Authors

Uraporn Phumisantiphong

Kanokrat Siripanichgon

Onrapak Reamtong

Pornphan Diraphat

Affiliations

Soon will be listed here.

Abstract

The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials. The aim of this study was to discover and characterize bacteriocin against clinical isolates of MDRE and VRE. Over 10,000 bacterial isolates from water, environment and clinical samples were screened. E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains. The optimum condition for bacteriocin production was cultivation in MRS broth at 37°C, pH 5-6 for 16 hours. The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60°C for at least 1 hour and retained its antimicrobial activity after storage at -20°C for 1 year, at 4°C for 6 months, and at 25°C for 2 months. A nano-HPLC electrospray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) analysis showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin. This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.

Citing Articles

Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections.

Naveed M, Waseem M, Mahkdoom I, Ali N, Asif F, Hassan J Front Antibiot. 2025; 2():1309107.

PMID: 39816650 PMC: 11732137. DOI: 10.3389/frabi.2023.1309107.

Identification and characterization of antibacterial peptides produced by 1407.

Sajan S, Saravanan R Bioimpacts. 2024; 14(6):29912.

PMID: 39493901 PMC: 11530969. DOI: 10.34172/bi.2024.29912.

The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects.

Youssef H, Azmy A, Eid H, Sayed O, Eldomany E, Farghali A Int Microbiol. 2024; 28(2):227-239.

PMID: 38775969 DOI: 10.1007/s10123-024-00534-6.

Interactions between commensal and and clinical isolates of .

Wagner T, Pontinen A, Fenzel C, Engi D, Janice J, Almeida-Santos A FEMS Microbes. 2024; 5:xtae009.

PMID: 38606354 PMC: 11008740. DOI: 10.1093/femsmc/xtae009.

Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy.

Hourigan D, Stefanovic E, Hill C, Ross R BMC Microbiol. 2024; 24(1):103.

PMID: 38539119 PMC: 10976773. DOI: 10.1186/s12866-024-03243-2.

References

Short B, Preisinger C, Schaletzky J, Kopajtich R, Barr F . The Rab6 GTPase regulates recruitment of the dynactin complex to Golgi membranes. Curr Biol. 2002; 12(20):1792-5. DOI: 10.1016/s0960-9822(02)01221-6. View

Nespolo C, Brandelli A . Production of bacteriocin-like substances by lactic acid bacteria isolated from regional ovine cheese. Braz J Microbiol. 2013; 41(4):1009-18. PMC: 3769745. DOI: 10.1590/S1517-838220100004000020. View

Humphries R, Bobenchik A, Hindler J, Schuetz A . Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition. J Clin Microbiol. 2021; 59(12):e0021321. PMC: 8601225. DOI: 10.1128/JCM.00213-21. View

Hu C, Dougan S, Virreira Winter S, Paton A, Paton J, Ploegh H . Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes. J Exp Med. 2009; 206(11):2429-40. PMC: 2768844. DOI: 10.1084/jem.20090782. View

van Loon L, Rep M, Pieterse C . Significance of inducible defense-related proteins in infected plants. Annu Rev Phytopathol. 2006; 44:135-62. DOI: 10.1146/annurev.phyto.44.070505.143425. View

Salgado C . The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control. 2008; 36(10):S175.e5-8. DOI: 10.1016/j.ajic.2008.10.010. View

Giraffa G . Functionality of enterococci in dairy products. Int J Food Microbiol. 2003; 88(2-3):215-22. DOI: 10.1016/s0168-1605(03)00183-1. View

Udby L, Cowland J, Johnsen A, Sorensen O, Borregaard N, Kjeldsen L . An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions. J Immunol Methods. 2002; 263(1-2):43-55. DOI: 10.1016/s0022-1759(02)00033-9. View

Tripathi L, Sowdhamini R . Genome-wide survey of prokaryotic serine proteases: analysis of distribution and domain architectures of five serine protease families in prokaryotes. BMC Genomics. 2008; 9:549. PMC: 2605481. DOI: 10.1186/1471-2164-9-549. View

10.

Balla E, Dicks L, du Toit M, van der Merwe M, Holzapfel W . Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecalis BFE 1071. Appl Environ Microbiol. 2000; 66(4):1298-304. PMC: 91984. DOI: 10.1128/AEM.66.4.1298-1304.2000. View

11.

Krojer T, Garrido-Franco M, Huber R, Ehrmann M, Clausen T . Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine. Nature. 2002; 416(6879):455-9. DOI: 10.1038/416455a. View

12.

Rajanbabu V, Chen J . Applications of antimicrobial peptides from fish and perspectives for the future. Peptides. 2010; 32(2):415-20. DOI: 10.1016/j.peptides.2010.11.005. View

13.

Lyon W, Caparon M . Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect Immun. 2004; 72(3):1618-25. PMC: 356025. DOI: 10.1128/IAI.72.3.1618-1625.2004. View

14.

Baldassarri L, Creti R, Montanaro L, Orefici G, Arciola C . Pathogenesis of implant infections by enterococci. Int J Artif Organs. 2005; 28(11):1101-9. DOI: 10.1177/039139880502801107. View

15.

Keren T, Yarmus M, Halevy G, Shapira R . Immunodetection of the bacteriocin lacticin RM: analysis of the influence of temperature and Tween 80 on its expression and activity. Appl Environ Microbiol. 2004; 70(4):2098-104. PMC: 383130. DOI: 10.1128/AEM.70.4.2098-2104.2004. View

16.

Birri D, Brede D, Forberg T, Holo H, Nes I . Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants. Appl Environ Microbiol. 2009; 76(2):483-92. PMC: 2805230. DOI: 10.1128/AEM.01597-09. View

17.

Basbulbul Ozdemir G, Oryasin E, Biyik H, Ozteber M, Bozdogan B . Phenotypic and genotypic characterization of bacteriocins in enterococcal isolates of different sources. Indian J Microbiol. 2012; 51(2):182-7. PMC: 3209898. DOI: 10.1007/s12088-011-0143-0. View

18.

Corsetti A, Settanni L, van Sinderen D . Characterization of bacteriocin-like inhibitory substances (BLIS) from sourdough lactic acid bacteria and evaluation of their in vitro and in situ activity. J Appl Microbiol. 2004; 96(3):521-34. DOI: 10.1111/j.1365-2672.2004.02171.x. View

19.

Gibbs G, Roelants K, OBryan M . The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins--roles in reproduction, cancer, and immune defense. Endocr Rev. 2008; 29(7):865-97. DOI: 10.1210/er.2008-0032. View

20.

Watorek W . Azurocidin -- inactive serine proteinase homolog acting as a multifunctional inflammatory mediator. Acta Biochim Pol. 2003; 50(3):743-52. View